Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
Catheter Cardiovasc Interv
; 102(6): 1020-1033, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37855169
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
Drug-Eluting Stents
/
Percutaneous Coronary Intervention
Limits:
Humans
Language:
En
Year:
2023
Type:
Article